TipRanks
Go Ultimate55% OFF

Gyre Therapeutics (L9S) Cash flow

Gyre Therapeutics Cash Flow

DE:L9S's free cash flow for Q2 2026 was $-18.01M. For the 2026 fiscal year, DE:L9S's free cash flow was decreased by $-1.29M and operating cash flow was $-16.73M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Mar 22
$ 1.01M$ -3.64M$ 25.89M$ 10.68M$ -83.75M
$ -474.00K$ -19.88M$ -19.76M$ -13.81M$ 48.19M
$ 24.38M$ 2.10M$ 2.50M$ 0.00$ 49.55M
$ 37.07M$ 11.81M$ 33.51M$ 25.18M$ 44.35M
$ -180.00K$ -6.77M$ 17.31M$ 5.68M$ -84.59M

Currency in USD

Gyre Therapeutics Cash Flow

-100M-50M050M100M150M201720182019202020212022202320242025OperatingInvestingFinancing